Site Search     
Dendritic Cell Based Cancer Vaccines
Genes of Health: Signature of Health and Disease in Humans
Human Dendritic Cell Biology
Humouse: An In Vivo Model of the Human Immune System
Infectious Diseases
Understanding of Systemic Lupus Erythematosus
Current BIIR Grants
Key BIIR Papers


Baylor Institute for Immunology Research
3434 Live Oak St.
Dallas, Texas 75204

Tel: (214) 820-7451
Fax: (214) 820-4813
Key BIIR Papers

2007		  
Steinman, R.M., and J. Banchereau. 2007. Taking dendritic cells into medicine. Nature 449:419-426.

  
Allantaz, F., D. Chaussabel, D. Stichweh, L. Bennett, W. Allman, A. Mejias, M. Ardura, W. Chung, C. Wise, K. Palucka, O. Ramilo, M. Punaro, J. Banchereau, and V. Pascual. 2007. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 204:2131-2144.

  
Aspord C, Pedroza-Gonzalez A, Gallegos M, Tindle S, Burton EC, Su D, Marches F, Banchereau J, Palucka AK (2007): Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med 204:1037-1047.

  
Cao, T., H. Ueno, C. Glaser, J.W. Fay, A.K. Palucka, and J. Banchereau. 2007. Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL. Eur J Immunol 37:2657-2667.

  
Dubsky, P., H. Saito, M. Leogier, C. Dantin, J.E. Connolly, J. Banchereau, and A.K. Palucka. 2007. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL. Eur J Immunol 37:1678-1690.

  
Ramilo, O., W. Allman, W. Chung, A. Mejias, M. Ardura, C. Glaser, K.M. Wittkowski, B. Piqueras, J. Banchereau, A.K. Palucka, and D. Chaussabel. 2007. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109:2066-2077.

  
Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, T. Di Pucchio, J. Connolly, J.W. Fay, V. Pascual, A.K. Palucka, and J. Banchereau. 2007. Dendritic cell subsets in health and disease. Immunol Rev 219:118-142.

  

2006		  
Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25:383-392.

  
Fay, J.W., A.K. Palucka, S. Paczesny, M. Dhodapkar, D.A. Johnston, S. Burkeholder, H. Ueno, and J. Banchereau. 2006. Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells. Cancer Immunol Immunother 55:1209-1218.

  
Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J. 2006. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. J Immunother. 2006 Sep-Oct;29(5):545-57.

  
Palucka AK, Banchereau J. 2006. Langerhans cells: daughters of monocytes. Nat Immunol. 7(3):223-4.

  
Pascual, V., L. Farkas, and J. Banchereau. 2006. Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol.

  
Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. 2006. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107(7):2613-8.

  
Ramilo, O., W. Allman, W. Chung, A. Mejias, M. Ardura, C. Glaser, K.M. Wittkowski, B. Piqueras, J. Banchereau, A.K. Palucka, and D. Chaussabel. 2006. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood. Pre-published online November 14, 2006.

  
Saito, H., D. Frleta, P. Dubsky, and A.K. Palucka. 2006. Dendritic cell-based vaccination against cancer. Hematol Oncol Clin North Am 20:689-710.

  
Shi H, Cao T, Connolly JE, Monnet L, Bennett L, Chapel S, Bagnis C, Mannoni P, Davoust J, Palucka AK, Banchereau J. 2006. Hyperthermia enhances CTL cross-priming. J Immunol. 176(4):2134-41.

  
   

2005		  
Banchereau, J., and A.K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296-306.

  
Banchereau J., H. Ueno, M. Dhodapkar, J. Connolly, J.P. Finholt, E. Klechevsky, J.P. Blanck, D.A. Johnston, A.K. Palucka, and J. Fay. 2005. Immune and Clinical Outcomes in Patients with Stage IV Melanoma Vaccinated with Peptide-Pulsed Dendritic Cells Derived From CD34+ Progenitors and Activated with Type I Interferon. J Immunother. 28(5):505-516.

  
Chaussabel D, Allman W, Mejias A, Chung W, Bennett L, Ramilo O, Pascual V, Palucka AK, Banchereau J. 2005. Analysis of significance patterns identifies ubiquitous and disease-specific gene-expression signatures in patient peripheral blood leukocytes. Ann N Y Acad Sci. 1062:146-54.

  
Chaussabel, D., and J. Banchereau. 2005. Dendritic cells, therapeutic vectors of immunity and tolerance. Am J Transplant 5:205-206.

  
Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK. 2005. Human dendritic cell subsets for vaccination. J Clin Immunol. 25(6):551-72.

  
Fay, J.R., J.A. Crowell, and L. Kopelovich. 2005. Targeting epigenetic regulatory mechanisms in cancer chemoprevention. Expert Opin Ther Targets 9:315-328.

 
Fay J.W., Palucka AK, Paczesny S, Dhodapkar M, Johnston DA, Burkeholder S, Ueno H, Banchereau J. 2005. Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells. Cancer Immunol Immunother. 1-10.

  
Jego, G., V. Pascual, A.K. Palucka, and J. Banchereau. 2005. Dendritic cells control B cell growth and differentiation. Curr Dir Autoimmun 8:124-139.

  
Paczesny, S., H. Shi, H. Saito, P. Mannoni, J. Fay, J. Banchereau, and A.K. Palucka. 2005. Measuring melanoma-specific cytotoxic T lymphocytes elicited by dendritic cell vaccines with a tumor inhibition assay in vitro. J Immunother 28:148-157.

  
Palucka, A.K., M.V. Dhodapkar, S. Paczesny, H. Ueno, J. Fay, and J. Banchereau. 2005. Boosting vaccinations with peptide-pulsed CD34+ progenitor-derived dendritic cells can expand long-lived melanoma peptide-specific CD8+ T cells in patients with metastatic melanoma. J Immunother 28:158-168.

  
Palucka, A.K., J.P. Blanck, L. Bennett, V. Pascual, and J. Banchereau. 2005. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci U S A 102:3372-3377.

  
Pascual, V., F. Allantaz, E. Arce, M. Punaro, and J. Banchereau. 2005. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201:1479-1486.

 
Rolland, A., L. Guyon, M. Gill, Y.H. Cai, J. Banchereau, K. McClain, and A.K. Palucka. 2005. Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J Immunol 174:3067-3071.

 
Stichweh, D.S., M. Punaro, and V. Pascual. 2005. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22:262-265.

  
Stone, M.J., G. Merlini, and V. Pascual. 2005. Autoantibody activity in Waldenstrom's macroglobulinemia. Clin Lymphoma 5:225-229.

  
Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med. 201(5):703-11.

  
   

2004		  
Banchereau, J., V. Pascual, and A.K. Palucka. 2004. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 20:539-550.

  
Banchereau, J., J. Fay, S. Paczesny, H. Ueno, M. Dhodapkarz, and A.K. Palucka. 2004. Dendritic cells as melanoma vaccines. Dev Biol (Basel) 116:147-156; discussion 179-186.

  
Chaussabel, D. 2004. Biomedical literature mining: challenges and solutions in the 'omics' era. American Journal of Pharmacogenomics 4:383-393.

  
Neidhardt-Berard, E.M., F. Berard, J. Banchereau, and A.K. Palucka. 2004. Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes. Breast Cancer Res 6:R322-328.

  
Paczesny, S., J. Banchereau, K.M. Wittkowski, G. Saracino, J. Fay, and A.K. Palucka. 2004. Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. J Exp Med 199:1503-1511.

  
Stichweh, D., E. Arce, and V. Pascual. 2004. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 16:577-587.

  
Ueno, H., I. Tcherepanova, O. Reygrobellet, E. Laughner, C. Ventura, A.K. Palucka, and J. Banchereau. 2004. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses. J Immunol Methods 285:171-180.

  
   

2003		  
Bennett, L., A.K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711-723.

 
Chomarat, P., C. Dantin, L. Bennett, J. Banchereau, and A.K. Palucka. 2003. TNF skews monocyte differentiation from macrophages to dendritic cells. J Immunol 171:2262-2269.

 
Jego, G., A.K. Palucka, J.P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau. 2003. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19:225-234.

  
Palucka, A.K., J. Gatlin, J.P. Blanck, M.W. Melkus, S. Clayton, H. Ueno, E.T. Kraus, P. Cravens, L. Bennett, A. Padgett-Thomas, F. Marches, M. Islas-Ohlmayer, J.V. Garcia, and J. Banchereau. 2003. Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood 102:3302-3310.

  
Palucka, A.K., M.V. Dhodapkar, S. Paczesny, S. Burkeholder, K.M. Wittkowski, R.M. Steinman, J. Fay, and J. Banchereau. 2003. Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma. J Immunother 26:432-439.

 
   

2002		  
Fay, J.W. 2002. Hematopoietic growth factors, dendritic cell biology, and vaccine therapy of cancer. Curr Opin Hematol 9:202-206.

 
Palucka, K., and J. Banchereau. 2002. How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr Opin Immunol 14:420-431.

  
   

2001		  
Banchereau , J., Schuler- Thurner , B., Palucka , A.K., and Schuler, G. (2001). Dendritic cells as vectors for therapy. Cell. 106:271-274.

  
Banchereau, J., A.K. Palucka, M. Dhodapkar, S. Burkeholder, N. Taquet, A. Rolland, S. Taquet, S. Coquery, K.M. Wittkowski, N. Bhardwaj, L. Pineiro, R. Steinman, and J. Fay. 2001. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res 61:6451-6458.

  
Blanco, P., A.K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294:1540-1543.

  
Mohamadzadeh, M., F. Berard, G. Essert, C. Chalouni, B. Pulendran, J. Davoust, G. Bridges, A.K. Palucka, and J. Banchereau. 2001. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med 194:1013-1020.

  
Pulendran, B., K. Palucka, and J. Banchereau. 2001. Sensing pathogens and tuning immune responses. Science 293:253-256.

  
   

2000		  
Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811.

  
Berard, F., P. Blanco, J. Davoust, E.M. Neidhart-Berard, M. Nouri-Shirazi, N. Taquet, D. Rimoldi, J.C. Cerottini, J. Banchereau, and A.K. Palucka. 2000. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med 192:1535-1544.

  
Chomarat, P., J. Banchereau, J. Davoust, and A.K. Palucka. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1:510-514.

  
Pulendran, B., J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, C. Chalouni, D. Caron, C. Maliszewski, J. Davoust, J. Fay, and K. Palucka. 2000. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 165:566-572.